SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 223 0
Emcee:  nigel bates Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
7324ARWR +20% on completing P1 enrollment??? i might take my money here...mopgcw-6/18/2018
7323GLMD now +150%/PM. The CC is in progress.DewDiligence_on_SI-6/12/2018
7322Galmed to release mid-stage data on NASH candidate Aramchol this morning; sharesJulius Wong16/12/2018
7321AXON has a slightly over exuberant pop today... BASEL, Switzerland, June 06, 20nigel bates-6/6/2018
7320Cash flow exceeds market cap by a factor of 3 if LDS expands its operation to 30james flannigan-6/1/2018
7319CARA has licensed worldwide rights — except in the U.S., Japan and South Korea —tnsaf-5/24/2018
7318AVXS around 90% on $8.7bn Novartis bid.nigel bates-4/9/2018
7317TCON +16%—possibly related to 13D filing: investorshub.advfn.comDewDiligence_on_SI-4/4/2018
7316GLMD +15% on unusual financing deal: investorshub.advfn.comDewDiligence_on_SI-4/3/2018
7315SLS +151% on phase-2b data in adjuvant breast cancer: investorshub.advfn.comDewDiligence_on_SI-4/2/2018
7314MYOK - any thoughts on the weak dose response in part B compared to part A? Thistuck-3/11/2018
7313MYOK - any thoughts on the weak dose response in part B compared to part A?semi_infinite -3/11/2018
7312RGNX up 25% - earnings call must have had something in it. Haven't had a chaSteve Lokness-3/7/2018
7311APLS +17% Delayed response to Thursday's news on P2 trial?tnsaf-2/27/2018
7310ACHN +15% European Medicines Agency Committee for Orphan Medicinal Products issutnsaf-2/27/2018
7309AVIR now trading as VXRT following yesterday's merger closing and concurrentDewDiligence_on_SI-2/14/2018
7308DBVT today announced that the U.S. Food and Drug Administration (FDA) has agreedtnsaf-2/14/2018
7307Kadmon (KDMN) up ~20% after hours after reporting positive results in a proof oftuck-2/12/2018
7306AVIR +20% on amended reverse-merger terms: investorshub.advfn.comDewDiligence_on_SI-2/8/2018
7305CASC 71% on SGEN buyout. unfortunately just gets me back to breakeven. alas. mopgcw-1/31/2018
7304If you sold on Thursday, you already had a GOOD, nice gain on it. <g> AlbeJibacoa-1/28/2018
7303Buyout rumors? I sold the last of my JUNO the day before that buyout was announcSteve Lokness-1/25/2018
7302In one of my least brilliant moves of 2017, I sold all my FMI after this 25% movsjemmeri-1/25/2018
7301MannKind (MNKD) up 25% on volume for no apparent reason. Tempting to short it. tuck-1/25/2018
7300Summit 30% OXFORD, United Kingdom, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Summit Thenigel bates11/25/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):